Sopko O. Cardiovascular risk and its modification in women with metabolic syndrome on the background of polycystic ovary syndrome

Українська версія

Thesis for the degree of Candidate of Sciences (CSc)

State registration number

0414U001595

Thesis Registration Form

0414U001595.pdf

Applicant for

Specialization

  • 14.01.11 - Кардіологія

25-03-2014

Specialized Academic Board

Д 26.616.01

State Institution National Scientific Center "The M.D. Strazhesko Institute of Cardiology National Academy of Medical Sciences of Ukraine"

Essay

The work is based on examination of 90 reproductive age polycystic ovary syndrome (PCOS) women with and without metabolic syndrome. We proved the feasibility of identifying cardiovascular risk factors and early markers of atherosclerosis: inhibition of the brachial artery endothelium-dependent flow-mediated vasodilation (FMD) and increased carotid intima-media thickness values compared to age normogram for reproductive age PCOS women. We investigated the possibility of cardiovascular risk factors and FMD correction and normalization by pharmacological and non-pharmacological therapy in PCOS women, especially during pregravid preparation.

Read more

Files

Автореферат.doc

Диссертация.doc

Диссертация.doc

Similar theses

0524U000129

Oksana L. Rekovets

Сlinical and pathogenetic justification of individual diagnostic approaches and treatment programs in resistant arterial hypertension

0523U100016

Maslovskyi Valentyn Iuriyovych

Prognostic value of various clinical and instrumental markers and options for basic therapy to assess the quality of life and the nature of the course of myocardial infarction without elevation of the ST segment

0421U103208

Kovbasniuk Yuriy Vasylovych

Structure and functional myocardial changes and features of plasma hemostasis by patient with atrial fibrillation and different body mass index

0821U101742

Tanska Olha Oleksandrivna

Criteria for Patients to be Put on the Waiting List for Heart Transplantation

0821U101115

Kutia Inna Mykolaivna

Pathogenetic and prognostic value of vascular endothelial growth factor-A in acute myocardial infarction with the ST segment elevation